Positron emission tomography and radioimmunotargeting - Aspects of quantification and dosimetry

Mark Lubberink, Hans Lundqvist, Jan Erik Westlin, Vladimir Tolmachev, Harald Schneider, Anna Lövqvist, Anders Sundin, Jörgen Carlsson

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Positron emission tomography (PET) is a medical imaging tool with high resolution and good quantitative properties, which makes it suitable for in vivo quantification of radioimmunotargeting agents. Most radionuclides used in radioimmunotherapy have positron-emitting analogues, which can be used for PET imaging, and this opens the possibility of performing dosimetry with PET. These isotopes, however, often emit gamma radiation and high-energy positrons in their decay, influencing the imaging properties of PET. Spatial resolution, reconstructed background and line source recovery for a number of non-pure positron emitters were investigated and compared with the imaging properties of 18F. PET imaging properties did not degrade severely for these non-pure positron emitters, but caution has to be applied when doing quantitative measurements. To assess the possibility of conducting PET studies during therapy, by combining, for example, a small amount of 124I with 131I, the influence of the presence of large amounts of gamma radiation on PET count rate characteristics was studied. The results of these studies were related to the necessary amounts of radioactivity needed for treatment of post-operative remains of glioma. The results indicate that the count rate capabilities of 2D PET permit PET studies for dose evaluation during radioimmunotherapy.

Original languageEnglish
Pages (from-to)343-349
Number of pages7
JournalActa Oncologica
Volume38
Issue number3
DOIs
Publication statusPublished - 1999
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Positron emission tomography and radioimmunotargeting - Aspects of quantification and dosimetry'. Together they form a unique fingerprint.

Cite this